Characterization of the arrhythmia substrates in hereditary in comparison to non-hereditary arrhythmogenic cardiomyopathy by cardiac magnetic resonance imaging

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00028632

Enrollment

Registered

2022-03-28

Start date

2022-07-01

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

I42.88 I47.2

Interventions

Group 1: 20 patients with hereditary arrhythmogenic cardiomyopathy undergo cardiac magnetic resonance imaging with delayed gadolinium enhancement (DE). The transmural extent of DE in different regions

Eligibility

Sex/Gender

All

Age

18 Years to 90 Years

Inclusion criteria

Inclusion criteria: arrhythmogenic cardiomyopathy

Exclusion criteria

Exclusion criteria: age 90 years

Design outcomes

Secondary

Measure	Time frame
clinical follow-up of patients	—

Primary

Measure	Time frame
The presence and extent of scar and fibrosis in different regions of the heart has been determined by cardio MRI in 20 patients with hereditary vs. 20 patients with non-hereditary arrhythmogenic cardiomyopathy. The aim of the case-control study is a comparison of these data obtained from 20 patients with hereditary vs. 20 patients with non-hereditary arrhythmogenic cardiomyopathy.	—

Countries

Germany

Contacts

Public ContactChristopher Reithmann

HELIOS Klinikum München WestKardiologie und Internistische Intensivmedizin

christopher.reithmann@helios-gesundheit.de49 89 8892 2307

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026